Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study (Q44129093)

30 November 2017

Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study (English)

1 reference

30 November 2017

1 reference

1 reference

1 reference

2

Laura Rubbia-Brandt

1 reference

30 November 2017

Laurent Spahr

1

1 reference

30 November 2017

Jean-Loius Frossard

3

1 reference

30 November 2017

Emile Giostra

4

1 reference

30 November 2017

Anne-Laure Rougemont

5

1 reference

30 November 2017

Jérôme Pugin

6

1 reference

30 November 2017

Maria Fischer

7

1 reference

30 November 2017

Hanspeter Egger

8

1 reference

30 November 2017

Antoine Hadengue

9

1 reference

30 November 2017

1 October 2002

1 reference

30 November 2017

Journal of Hepatology

1 reference

30 November 2017

37

1 reference

30 November 2017

4

1 reference

30 November 2017

448-455

1 reference

A randomized trial of prednisolone in patients with severe alcoholic hepatitis

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900230-1

7 January 2021

Prognosis in Acute Liver Disease of the Alcoholic Patient

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900230-1

7 January 2021

Role of tumor necrosis factor-alpha in disease states and inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900230-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900230-1

1 reference

7 January 2021

Endotoxin, endotoxin-neutralizing-capacity, sCD14, sICAM-1, and cytokines in patients with various degrees of alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900230-1

7 January 2021

Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900230-1

7 January 2021

Cytokines in alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900230-1

7 January 2021

Is the intercellular adhesion molecule-1/leukocyte function associated antigen 1 pathway of leukocyte adhesion involved in the tissue damage of alcoholic hepatitis?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900230-1

7 January 2021

Rapid changes in alcoholic hepatitis histology under steroids: correlation with soluble intercellular adhesion molecule-1 in hepatic venous blood

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900230-1

7 January 2021

Clinical and biological relevance of hepatocyte apoptosis in alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900230-1

7 January 2021

Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900230-1

7 January 2021

Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900230-1

7 January 2021

Increased plasma tumor necrosis factor in severe alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900230-1

7 January 2021

Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900230-1

7 January 2021

Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900230-1

7 January 2021

Blood neutrophil functions and cytokine release in severe alcoholic hepatitis: effect of corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900230-1

7 January 2021

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900230-1

7 January 2021

Infliximab for the treatment of fistulas in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900230-1

7 January 2021

Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900230-1

7 January 2021

Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900230-1

7 January 2021

Mortality associated with infliximab

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900230-1

7 January 2021

Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900230-1

7 January 2021

Pharmacokinetic considerations in the treatment of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900230-1

7 January 2021

Cytochemical Diagnosis of Acute Myelomonocytic Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900230-1

7 January 2021

Immunohistochemical study of adhesion molecules in liver inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900230-1

7 January 2021

Serum intercellular adhesion molecule-1 in alcoholic liver disease and its relationship with histological disease severity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900230-1

7 January 2021

Serum levels of interleukin-8 in alcoholic liver disease: relationship with disease stage, biochemical parameters and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900230-1

7 January 2021

Increased plasma interleukin-8 concentrations in alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900230-1

7 January 2021

Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFalpha in patients with rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900230-1

7 January 2021

Cytokines in alcoholic and nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900230-1

7 January 2021

10.1016/S0168-8278(02)00230-1

Identifiers

DOI

1 reference

30 November 2017

1 reference